<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC303340/" ref="ordinalpos=930&amp;ncbi_uid=340843&amp;link_uid=PMC303340" image-link="/pmc/articles/PMC303340/figure/f8/" class="imagepopup">FIG. 8. From: Activation of the RAS/Cyclic AMP <span class="highlight" style="background-color:">Pathway</span> Suppresses a TOR Deficiency in Yeast. </a></div><br /><div class="p4l_captionBody">Model of rapamycin-sensitive TOR signaling in the control of cell growth. Rapamycin-sensitive TOR signaling bifurcates into two separate effector pathways, TAP42/SIT4 and RAS/cAMP/PKA. Each effector pathway controls a specific subset of TOR readouts. For details, see Discussion.</div></div>